MedPath

City Of Hope National Medical Center

City Of Hope National Medical Center logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1913-01-01
Employees
10K
Market Cap
-
Website
http://www.cityofhope.org

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

No trials found

News

Lung Cancer Experts Convene to Address Clinical Uncertainties in Rapidly Evolving Treatment Landscape

The third annual Bridging the Gaps in Lung Cancer consensus meeting brings together approximately 30 global experts to identify and address unresolved clinical challenges in lung cancer management.

Community Engagement Emerges as Critical Bridge Between Cancer Research and Policy Development

Community engagement is fundamental to cancer science, helping researchers address the intersection of cancer, society, and community needs while improving scientific trustworthiness in community settings.

CareDx's AlloHeme Test Shows 93% Sensitivity in Early Detection of AML and MDS Relapse Post-Transplant

Interim results from the ACROBAT study demonstrate AlloHeme's superior accuracy in detecting post-transplant relapse in AML and MDS patients, with 93% sensitivity and 88% specificity.

Lutetium-177 Dotatate Shows Promise in Neuroendocrine Tumors, Combination Strategies Explored

Lutetium-177 Dotatate (Lutathera) has demonstrated efficacy in treating well-differentiated neuroendocrine tumors (NETs), improving progression-free survival in advanced cases.

Acalabrutinib Regimen Shows Promise in Untreated Mantle Cell Lymphoma

Acalabrutinib, umbralisib, and ublituximab (AU2) demonstrated a 100% objective response rate in patients with de novo mantle cell lymphoma (MCL).

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.